COVID-19 has kept medical science liaisons grounded for more than a year. In response, they’ve been busy mastering the art of the digital connection to continue delivering crucial scientific information to healthcare practitioners and key opinion leaders. In PharmaVOICE, Rohit Gupta discusses the changing role of medical science liaisons as a result of the COVID-19 pandemic.